Asian News International on MSN13d
Attentive.ai completes $12M Series A round to expand AI offerings for the construction industryAttentive.ai, a leading AI-based SaaS startup, today announced the successful close of its Series A2 funding round, ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
UnitedHealth reported fourth-quarter adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72.
U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its ...
In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $433.00. The company’s shares ...
Vertex's Journavx got FDA approval for acute pain but faces adoption challenges: variable efficacy vs opioids, generic competition, and entrenched prescriber habits limit near-term potential ...
Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals ... UK health system to offer cutting-edge gene therapy for sickle cell disease January 31, 2025 ...
The Aerospace Corporation (Aerospace), a national nonprofit operating the only federally funded research and development ...
The VERTEX 80 and the VERTEX 80v vacuum FT-IR spectrometers from Bruker are based on the actively aligned UltraScan ™ interferometer, which provides PEAK spectral resolution. The precise linear ...
Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts adjusted earnings below expectations. Vertex Pharmaceuticals could soon capture $10 billion in sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback